EFG
LABU icon

Ethos Financial Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Ethos Financial Group’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$968K Sell
3,315
-600
-15% -$115K 0.06% 233
2026
Q1 		$624K Hold
3,915
– – 0.05% 275
2025
Q4 		$624K Sell
3,915
-4,957
-56% -$681K 0.05% 260
2025
Q3 		$831K Sell
8,872
-183
-2% -$12.9K 0.07% 201
2025
Q2 		$515K Buy
9,055
+2,270
+33% +$120K 0.04% 258
2025
Q1 		$414K Buy
+6,785
New +$578K 0.04% 268

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ethos Financial Group's LABU Position: Q2 2026 in Review

Ethos Financial Group reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 15% in Q2 2026, selling an estimated $115K and leaving 3,315 shares worth $968K. The position accounts for 0.06% of the portfolio, ranked #233.

Ethos Financial Group first reported a position in LABU in Q1 2025 and has held it in 6 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Ethos Financial Group held 3,315 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $968K as of Q2 2026.
  • Ethos Financial Group sold 600 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $115K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.06% of Ethos Financial Group's portfolio in Q2 2026, its #233 holding.
  • Ethos Financial Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2025 and has held it in 6 quarters since.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.